alexa Ocular Application Of Dirithromycin With Chitosan Based Polymeric Nanoparticles
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Nanotek & Expo
December 01-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Ebru Basaran, Evrim Y Enilmez, G?lsel Yurtdaş Kırımlıoglu and Yasemin Yazan
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439.S1.017
Dirithromycin belongs to the new generation of the macrolide antibiotic family. It is more powerful and shows longer efficacy with much shorter treatment period than erythromycin. Treatment of ocular bacterial infections remains problematic because of thelimited ocular bioavailability of active agents. Due to the characteristic properties of the eye (normal tear turnover, nasolacrimal drainage, cornea?s barrier effect etc.) efficacy of the treatment mostly remains insufficient. Therefore main approaches for the enhancement of ocular bioavailability of the formulations applied are enhancement of the residence time of the active material at the site of action or enhancement of the ocular penetration of the primary penetration site. Chitosan has attracted a lot of attention in ocular applications as a potential penetration enhancer across the mucosal epithelia due to its polycationic, biocompatible and biodegradable nature together with its mucoadhesive property. Therefore in this study, polymeric nanoparticles originated from Chitosan were formulated for the enhancement of ocular bioavailability of Dirithromycin for the sufficient treatment of common bacterial infections.
Ebru Basaran got her MSc on ?Sunscreens (Cosmetics)? in 2003 and she had completed her PhD study on ?Controlled Drug Delivery Systems? in 2007. Since 2007 she has been working as an Assistant Professor at the Department of Pharmaceutical Technology at Anadolu University. She was entitled for scholarships by Deutscher Akademischer Austausch Dienst (DAAD) and Academic Exchange Grant by ERASMUS. She was awarded with ?Best Research Study Award? by Nagai Foundation. She has several publications and presentations about ?Controlled Drug Delivery Systems for Ocular Applications?. She also contributes to Pharmaceutical Journals as an active reviewer.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version